Hallux Secures $7.1M
Laguna Hills-based Hallux, an investigational-stage pharmaceutical company focused on developing a new dosage form and route of administration for treating onychomycosis, announced the completion of Series A financing of $7.1 million. Deerfield Management led the round. Hallux is developing an…